CN Patent

CN102225203A — 一种用于降低血压的药用组合物

Assigned to Beijing Fukangren Bio Pharm Tech Co Ltd · Expires 2011-10-26 · 15y expired

What this patent protects

本发明为一种用于降低血压的药用组合物，是以阿齐沙坦酯和另外1-2种降压物质为活性成分的药用组合物，主要包括钙离子拈抗剂、血管紧张素转换酶抑制剂(ACEI)，以及氢氯噻嗪。本发明所述的组合物可可制成口服制剂用于高血压症的治疗。

USPTO Abstract

本发明为一种用于降低血压的药用组合物，是以阿齐沙坦酯和另外1-2种降压物质为活性成分的药用组合物，主要包括钙离子拈抗剂、血管紧张素转换酶抑制剂(ACEI)，以及氢氯噻嗪。本发明所述的组合物可可制成口服制剂用于高血压症的治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN102225203A
Jurisdiction
CN
Classification
—
Expires
2011-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Beijing Fukangren Bio Pharm Tech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.